Product details:
| ISBN13: | 9781108971638 |
| ISBN10: | 1108971636 |
| Binding: | Paperback |
| No. of pages: | 644 pages |
| Size: | 246x189x29 mm |
| Weight: | 1390 g |
| Language: | English |
| 1474 |
Category:
Stahl's Essential Psychopharmacology
Neuroscientific Basis and Practical Applications
Edition number: 5, Revised
Publisher: Cambridge University Press
Date of Publication: 29 July 2021
Normal price:
Publisher's listprice:
GBP 94.99
GBP 94.99
Your price:
41 292 (39 326 HUF + 5% VAT )
discount is: 10% (approx 4 588 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
Not in stock at Prospero.
Short description:
The fully-updated fifth edition covers the essential information required to become a neurobiologically empowered psychopharmacologist.
Long description:
Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
'The opportunity to review and comment on Stahl's Essential Psychopharmacology, 5th edition, is truly a pleasure. The depth and comprehension of this edition reads like a fresh view of everything we would want to know in the area of psychopharmacology, including the integration of basic and clinical neuroscience information. The clarity as a teaching tool for any level of education and sophistication is remarkable, just as is the ease of reading and enjoying the unique set of figures and tables. The book represents a departure from the usual fare that we are offered as we delve into the mysteries of our body. In short, this 5th edition is not a simple reworking of earlier editions but really a brand new view. It represents a model for the way that we should cover other areas of neuroscience.' Ellen Frank, Ph.D., Distinguished Professor Emeritus of Psychiatry, University of Pittsburgh School of Medicine
'The opportunity to review and comment on Stahl's Essential Psychopharmacology, 5th edition, is truly a pleasure. The depth and comprehension of this edition reads like a fresh view of everything we would want to know in the area of psychopharmacology, including the integration of basic and clinical neuroscience information. The clarity as a teaching tool for any level of education and sophistication is remarkable, just as is the ease of reading and enjoying the unique set of figures and tables. The book represents a departure from the usual fare that we are offered as we delve into the mysteries of our body. In short, this 5th edition is not a simple reworking of earlier editions but really a brand new view. It represents a model for the way that we should cover other areas of neuroscience.' Ellen Frank, Ph.D., Distinguished Professor Emeritus of Psychiatry, University of Pittsburgh School of Medicine
Table of Contents:
Preface to the Fifth Edition; CME Information; 1. Chemical Neurotransmission; 2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action; 3. Ion Channels as Targets of Psychopharmacological Drug Action; 4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate; 5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'; 6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba); 7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'; 8. Anxiety, Trauma and Treatment; 9. Chronic Pain and its Treatment; 10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin; 11. Attention Deficit Hyperactivity Disorder and its Treatment; 12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine; 13. Impulsivity, Compulsivity and Addiction; Suggested Reading and Selected References; Index.
